88 related articles for article (PubMed ID: 9438093)
1. T-cell activation modified by parathyroid hormone (PTH) in patients with end-stage renal disease.
Kaneko T; Osono E; Hayama N; Lino Y; Terashi A
Clin Nephrol; 1997 Dec; 48(6):353-8. PubMed ID: 9438093
[TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
3. Immunologic disturbances and levels of parathyroid hormone in uremic patients in replacement dialysis therapy.
Angelini D; Carlini A; Mazzotta L; Mei E; Grassi R; Giusti R; Neri M; Fiorini I; Antonelli A
Clin Nephrol; 1994 Oct; 42(4):246-50. PubMed ID: 7834917
[TBL] [Abstract][Full Text] [Related]
4. Determinants of soluble CD23 antigen levels in hemodialysis patients: effect of 1.25 dihydroxyvitamin D3 and recombinant human erythropoietin treatment.
Altun B; Erdem Y; Usalan C; Arici M; Haznedaroglu IC; Yasavul U; Turgan C; Caglar S; Kirazli S
Clin Nephrol; 1999 Oct; 52(4):230-8. PubMed ID: 10543325
[TBL] [Abstract][Full Text] [Related]
5. Cellular immunity and levels of parathyroid hormone in uremic patients receiving hemodialysis.
Griveas I; Visvardis G; Papadopoulou D; Mitsopoulos E; Kyriklidou P; Manou E; Meimaridou D; Ginikopoulou E; Sakellariou G; Fleva A; Zilidou R; Paulitou A
Ren Fail; 2005; 27(3):275-8. PubMed ID: 15957542
[TBL] [Abstract][Full Text] [Related]
6. Acute effects of dialysis on T lymphocytes in patients with end-stage renal disease.
Chandy KG; Pahl M; Vaziri ND; Gupta S
J Clin Lab Immunol; 1985 Jul; 17(3):119-24. PubMed ID: 3930749
[TBL] [Abstract][Full Text] [Related]
7. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A
J Ayub Med Coll Abbottabad; 2004; 16(2):3-8. PubMed ID: 15455608
[TBL] [Abstract][Full Text] [Related]
8. Parathyroid hormone changes during phosphorus load in patients with chronic renal insufficiency with low serum parathyroid hormone or adynamic bone disease.
Cuppari L; Carvalho AB; Lobão RR; Martini LA; Cendoroglo M; Ventura RT; Draibe SA
Clin Nephrol; 2001 Jul; 56(1):35-43. PubMed ID: 11499657
[TBL] [Abstract][Full Text] [Related]
9. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A; Naderi AS
Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479
[TBL] [Abstract][Full Text] [Related]
10. Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease.
Zisman AL; Hristova M; Ho LT; Sprague SM
Am J Nephrol; 2007; 27(1):36-43. PubMed ID: 17215573
[TBL] [Abstract][Full Text] [Related]
11. T cells and B cells in chronic renal failure.
Descamps-Latscha B; Chatenoud L
Semin Nephrol; 1996 May; 16(3):183-91. PubMed ID: 8734461
[TBL] [Abstract][Full Text] [Related]
12. Immune response in hemodialysis patients: is there any difference when low and high iPTH levels are compared?
Tzanno-Martins C; Futata E; Jorgetti V; Duarte AJ
Clin Nephrol; 2000 Jul; 54(1):22-9. PubMed ID: 10939753
[TBL] [Abstract][Full Text] [Related]
13. Diminished chemokine and cytokine-induced adhesion of CD4+ T cells to extracellular matrix ligands in patients with end-stage renal failure.
Zeltzer E; Bernheim J; Korzets Z; Zeeli D; Rathaus M; Mekori YA; Hershkoviz R
Isr Med Assoc J; 2000 Apr; 2(4):282-6. PubMed ID: 10804903
[TBL] [Abstract][Full Text] [Related]
14. Evidence of impaired T cell function in hemodialysis patients: potential role for secondary hyperparathyroidism.
Alexiewicz JM; Gaciong Z; Klinger M; Linker-Israeli M; Pitts TO; Massry SG
Am J Nephrol; 1990; 10(6):495-501. PubMed ID: 2075908
[TBL] [Abstract][Full Text] [Related]
15. Influence of sevelamer hydrochloride on serum concentration of whole (1-84) and N-terminally truncated (7-84) parathyroid hormone fragments in hemodialysis uremic patients.
Chudek J; Piecha G; Kokot F; Wiecek A
J Nephrol; 2003; 16(5):710-5. PubMed ID: 14733418
[TBL] [Abstract][Full Text] [Related]
16. Calcitropic hormonal status in north Indian patients with end-stage renal disease.
Singh AK; Avula S; Kher V; Rao DS; Mithal A
Natl Med J India; 1999; 12(5):202-7. PubMed ID: 10612998
[TBL] [Abstract][Full Text] [Related]
17. Studies on T-cell colony formation in chronic renal failure (CRF) patients.
Wakabayashi Y; Sugimoto M; Ishiyama T; Horie S; Abe S; Hirose S; Okuda T
Clin Nephrol; 1989 Dec; 32(6):270-5. PubMed ID: 2612072
[TBL] [Abstract][Full Text] [Related]
18. Circulating growth hormone binding protein levels and mononuclear cell growth hormone receptor expression in uremia.
Greenstein J; Guest S; Tan JC; Tummala P; Busque S; Rabkin R
J Ren Nutr; 2006 Apr; 16(2):141-9. PubMed ID: 16567271
[TBL] [Abstract][Full Text] [Related]
19. Increased activation of protein kinase A type I contributes to the T cell deficiency in common variable immunodeficiency.
Aukrust P; Aandahl EM; Skålhegg BS; Nordøy I; Hansson V; Taskén K; Frøland SS; Müller F
J Immunol; 1999 Jan; 162(2):1178-85. PubMed ID: 9916750
[TBL] [Abstract][Full Text] [Related]
20. Parathyroid hormone inhibits B cell proliferation: implications in chronic renal failure.
Alexiewicz JM; Klinger M; Pitts TO; Gaciong Z; Linker-Israeli M; Massry SG
J Am Soc Nephrol; 1990 Sep; 1(3):236-44. PubMed ID: 1966555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
